Cargando…

Impaction grafting of the acetabulum with ceramic bone graft substitute mixed with femoral head allograft: High survivorship in 43 patients with a median follow-up of 7 years: A follow-up report

BACKGROUND AND PURPOSE: Restoration of bone stock at revision hip surgery remains a challenge. Alternative graft materials with suitable mechanical properties for impaction grafting have been sought due to issues with infection, antigenicity, cost, and availability of allograft. We have previously p...

Descripción completa

Detalles Bibliográficos
Autores principales: Whitehouse, Michael R, Dacombe, Peter J, Webb, Jason C J, Blom, Ashley W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2013
Materias:
Hip
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3768035/
https://www.ncbi.nlm.nih.gov/pubmed/23594223
http://dx.doi.org/10.3109/17453674.2013.792031
_version_ 1782283734773399552
author Whitehouse, Michael R
Dacombe, Peter J
Webb, Jason C J
Blom, Ashley W
author_facet Whitehouse, Michael R
Dacombe, Peter J
Webb, Jason C J
Blom, Ashley W
author_sort Whitehouse, Michael R
collection PubMed
description BACKGROUND AND PURPOSE: Restoration of bone stock at revision hip surgery remains a challenge. Alternative graft materials with suitable mechanical properties for impaction grafting have been sought due to issues with infection, antigenicity, cost, and availability of allograft. We have previously presented good short-term results of the use of BoneSave, a biphasic porous ceramic bone graft substitute, consisting of sintered 80% tricalcium phosphate and 20% hydroxyapatite, in a 50:50 mix with femoral head allograft. We now present the medium-term results. METHODS: We conducted a retrospective review of a cohort of 43 consecutive patients undergoing impaction grafting of contained acetabular defects by multiple surgeons at a single center. 34 patients received uncemented acetabular components and 9 received cemented components. Patients were followed up radiographically and with the self-reported satisfaction scale (SAPS), Oxford hip score (OHS), and the Short-Form 12 (SF12) health survey. Kaplan-Meier survivorship analysis was performed with revision of the acetabular component, revision of any part of the construct, and reoperation as endpoints. RESULTS: The fate of all cases was known. Median follow-up of the surviving patients was 80 (69–106) months. 15 patients died during the follow-up period, 14 with their construct in situ. The survivorship of the grafted acetabulum and acetabular component was 94% (95% CI: 99–78) at 7 years. 1 patient had been revised for aseptic loosening of the acetabulum and 1 for deep infection. The mean OHS was 31 (SD 12), the mean SF12 physical-component score (PCS) was 38 (SD 13), the median SAPS was 83 (0–100), and the median SF12 mental-component score (MCS) was 55 (23–65). The graft material became incorporated in all 3 zones of the acetabulum in 23 out of 24 cases that had complete radiographic follow-up. INTERPRETATION: These medium-term results show that BoneSave is a reliable material for impaction grafting of the acetabulum when used in conjunction with femoral head allograft.
format Online
Article
Text
id pubmed-3768035
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Informa Healthcare
record_format MEDLINE/PubMed
spelling pubmed-37680352013-09-16 Impaction grafting of the acetabulum with ceramic bone graft substitute mixed with femoral head allograft: High survivorship in 43 patients with a median follow-up of 7 years: A follow-up report Whitehouse, Michael R Dacombe, Peter J Webb, Jason C J Blom, Ashley W Acta Orthop Hip BACKGROUND AND PURPOSE: Restoration of bone stock at revision hip surgery remains a challenge. Alternative graft materials with suitable mechanical properties for impaction grafting have been sought due to issues with infection, antigenicity, cost, and availability of allograft. We have previously presented good short-term results of the use of BoneSave, a biphasic porous ceramic bone graft substitute, consisting of sintered 80% tricalcium phosphate and 20% hydroxyapatite, in a 50:50 mix with femoral head allograft. We now present the medium-term results. METHODS: We conducted a retrospective review of a cohort of 43 consecutive patients undergoing impaction grafting of contained acetabular defects by multiple surgeons at a single center. 34 patients received uncemented acetabular components and 9 received cemented components. Patients were followed up radiographically and with the self-reported satisfaction scale (SAPS), Oxford hip score (OHS), and the Short-Form 12 (SF12) health survey. Kaplan-Meier survivorship analysis was performed with revision of the acetabular component, revision of any part of the construct, and reoperation as endpoints. RESULTS: The fate of all cases was known. Median follow-up of the surviving patients was 80 (69–106) months. 15 patients died during the follow-up period, 14 with their construct in situ. The survivorship of the grafted acetabulum and acetabular component was 94% (95% CI: 99–78) at 7 years. 1 patient had been revised for aseptic loosening of the acetabulum and 1 for deep infection. The mean OHS was 31 (SD 12), the mean SF12 physical-component score (PCS) was 38 (SD 13), the median SAPS was 83 (0–100), and the median SF12 mental-component score (MCS) was 55 (23–65). The graft material became incorporated in all 3 zones of the acetabulum in 23 out of 24 cases that had complete radiographic follow-up. INTERPRETATION: These medium-term results show that BoneSave is a reliable material for impaction grafting of the acetabulum when used in conjunction with femoral head allograft. Informa Healthcare 2013-08 2013-09-02 /pmc/articles/PMC3768035/ /pubmed/23594223 http://dx.doi.org/10.3109/17453674.2013.792031 Text en Copyright: © Nordic Orthopaedic Federation http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the source is credited.
spellingShingle Hip
Whitehouse, Michael R
Dacombe, Peter J
Webb, Jason C J
Blom, Ashley W
Impaction grafting of the acetabulum with ceramic bone graft substitute mixed with femoral head allograft: High survivorship in 43 patients with a median follow-up of 7 years: A follow-up report
title Impaction grafting of the acetabulum with ceramic bone graft substitute mixed with femoral head allograft: High survivorship in 43 patients with a median follow-up of 7 years: A follow-up report
title_full Impaction grafting of the acetabulum with ceramic bone graft substitute mixed with femoral head allograft: High survivorship in 43 patients with a median follow-up of 7 years: A follow-up report
title_fullStr Impaction grafting of the acetabulum with ceramic bone graft substitute mixed with femoral head allograft: High survivorship in 43 patients with a median follow-up of 7 years: A follow-up report
title_full_unstemmed Impaction grafting of the acetabulum with ceramic bone graft substitute mixed with femoral head allograft: High survivorship in 43 patients with a median follow-up of 7 years: A follow-up report
title_short Impaction grafting of the acetabulum with ceramic bone graft substitute mixed with femoral head allograft: High survivorship in 43 patients with a median follow-up of 7 years: A follow-up report
title_sort impaction grafting of the acetabulum with ceramic bone graft substitute mixed with femoral head allograft: high survivorship in 43 patients with a median follow-up of 7 years: a follow-up report
topic Hip
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3768035/
https://www.ncbi.nlm.nih.gov/pubmed/23594223
http://dx.doi.org/10.3109/17453674.2013.792031
work_keys_str_mv AT whitehousemichaelr impactiongraftingoftheacetabulumwithceramicbonegraftsubstitutemixedwithfemoralheadallografthighsurvivorshipin43patientswithamedianfollowupof7yearsafollowupreport
AT dacombepeterj impactiongraftingoftheacetabulumwithceramicbonegraftsubstitutemixedwithfemoralheadallografthighsurvivorshipin43patientswithamedianfollowupof7yearsafollowupreport
AT webbjasoncj impactiongraftingoftheacetabulumwithceramicbonegraftsubstitutemixedwithfemoralheadallografthighsurvivorshipin43patientswithamedianfollowupof7yearsafollowupreport
AT blomashleyw impactiongraftingoftheacetabulumwithceramicbonegraftsubstitutemixedwithfemoralheadallografthighsurvivorshipin43patientswithamedianfollowupof7yearsafollowupreport